• Sign up
  • Login

Scheme Profile

Mirae Asset Healthcare Fund - Regular (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
2,770
Inception Date
02-07-2018
Category
Equity - Sectoral - Pharma

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 39.636 (09-Oct-2024) / 26.833 (23-Nov-2023)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 36.85 ( 0.31) ( 0.85 %)
  • Benchmark
  • BSE Healthcare TRI
  • Fund Manager
  • Vrijesh Kasera
  • Value of () 1,00,000 since inception
  • 3,68,530
  • Entry Load
  • NIL
  • Exit Load
  • 15% of the units allotted (including Switch-in/STP - in on or before completion of 365 days from the date of allotment of units: Nil. 1.00% - If redeemed within 1 year (365 days) from the date of allotment. Nil - If redeemed after 1 Year (365 days) from the date of allotment.
  • Expense Ratio (%)
  • 2.46
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 50.70 times
  • Portfolio P/B
  • 10.36 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 0.34

Risk Factors

  • Jenson's Alpha
  • -1.27
  • Standard Deviation
  • 4.39
  • Beta
  • 0.94
  • Sharpe
  • 0.29
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.36

NAV Movement

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

AUM Growth ( Cr.)

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • BSE Healthcare TRI
  • 10.35
  • -0.51
  • 15.09
  • 48.32
  • 13.19
  • 22.14
  • 13.77
  • -

Company Top 5 Holdings

  [ As on 31 Oct 2024 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceuticals Industries Ltd
  • Equity
  • 17,97,418
  • 12.00
  • Aurobindo Pharma Ltd
  • Equity
  • 15,96,058
  • 8.05
  • Cipla Ltd
  • Equity
  • 12,13,520
  • 6.80
  • Glenmark Pharmaceuticals Ltd
  • Equity
  • 10,13,543
  • 6.20
  • Dr Reddys Laboratories Ltd
  • Equity
  • 13,14,980
  • 6.05

Sector Top 5 Holdings

  [ As on 31 Oct 2024 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 1,35,29,507
  • 82.40
  • Healthcare
  • 44,57,467
  • 16.22
  • Chemicals
  • 1,72,067
  • 1.38

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 29.31 31.98 10.35 7.34 2,770.21
2023 34.45 31.12 38.35 18.10 2,035.25
2022 -11.94 -9.58 -11.31 2.80 1,631.86
2021 25.76 17.96 20.57 21.69 1,935.10
2020 73.37 65.84 62.19 15.60 1,209.93
2019 6.24 4.22 -3.06 13.79 366.91
2018 2.65 -2.00 -5.45 6.67 314.94

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Sep-2024 19.37 19.55 0 0 2,793.61
Jun-2024 3.42 3.76 0 0 2,312.48
Mar-2024 9.26 9.70 10.84 1.91 2,235.15
Dec-2023 9.71 11.42 11.01 10.27 2,035.25

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Quick links

Close